Mn Services Vermogensbeheer B.V. United Therapeutics Corp Transaction History

Mn Services Vermogensbeheer B.V.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$214.88 - $256.94 $171,904 - $205,552	-800 Reduced 3.62%	21,300 $4.68 Million
Q2 2023 Aug 09, 2023	BUY	$205.19 - $232.99 $4.53 Million - $5.15 Million	22,100 New	22,100 $4.88 Million
Q2 2019 Jul 25, 2019	SELL	$76.06 - $120.81 $562,767 - $893,873	-7,399 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$101.4 - $128.73 $60,840 - $77,238	600 Added 8.82%	7,399 $705,000
Q1 2018 May 11, 2018	SELL	$107.21 - $151.94 $42,884 - $60,776	-400 Reduced 5.56%	6,799 $764,000
Q4 2017 Feb 02, 2018	SELL	$118.58 - $151.28 $11,858 - $15,128	-100 Reduced 1.37%	7,199 $887,000
Q3 2017 Nov 01, 2017	BUY	$114.6 - $136.81 $836,465 - $998,576	7,299	7,299 $855,000

671

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.